title: [Use of sulprostone in abortion induced during the first pregnancy trimester in women with previous cesarean section].
abstract: The paper describes the advantages and negligible side-effects of the use of E2-type (Suprostone) synthetic prostaglandin, administered i.m. in a dose of 250 mg, 2-3 hours before voluntary abortion during the first trimester of pregnancy in pre-cesarean-section patients.
authors.affiliation: Divisione Ostetrico-Gonecologica, Presidio Ospedaliero di Casorate Primo, USSL 77 di Pavia.
authors.forename: R
authors.initials: R
authors.lastname: Giannone
authors.forename: F
authors.initials: F
authors.lastname: Bernardi
authors.forename: E
authors.initials: E
authors.lastname: Ferrari
authors.forename: M
authors.initials: M
authors.lastname: Poli
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced; D000328:Adult; D002585:Cesarean Section; D015232:Dinoprostone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011300:Preoperative Care
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; C016767:sulprostone; D015232:Dinoprostone
vernacular_title: L'impiego del Sulprostone nelle precesarizzate in corso di IVG nel I trimestre.